Loading provider…
Loading provider…
Hematology & Oncology Physician in Milwaukee, WI
NPI: 1063641157Primary Practice Location
FROEDTERT MEMORIAL LUTHERAN HOSPITAL
900 N 92nd St, Milwaukee, WI
Primary Employer
The Medical College of Wisconsin, Inc.
mcw.edu
HQ Phone
Get MD Sameem's Phone Numberphone_androidMobile
Get MD Sameem's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
MI State Medical License
IL State Medical License
WI State Medical License
WI State Medical License
2017 - 2025
IL State Medical License
2014 - 2017
MI State Medical License
2012 - 2016
PA State Medical License
2009 - 2012

American Board of Internal Medicine
Medical Oncology
Sidney Kimmel Medical College
jefferson.edu
Medical School
Until 2009
McGaw Medical Center of Northwestern University
Fellowship • Hematology and Medical Oncology
2014 - 2017
UPMC Medical Education
Residency • Internal Medicine
2009 - 2012
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 41 | 124 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 38 | 90 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 29 | 96 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 28 | 76 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 25 | 68 |
Authors: Saurabh Chhabra, Binod Dhakal, Parameswaran Hari, Laura Michaelis, Timothy Fenske, Meera Mohan
Journal: Clin Lymphoma Myeloma Leuk
Publication Date: 2022-01-19
Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database.
Authors: Ehab Atallah
Publication Date: 2019-02-21
Lead Sponsor: Autolus Limited
Intervention / Treatment: BIOLOGICAL: AUTO1
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: 5-Azacitidine, DRUG: GSK3326595
Lead Sponsor: Sameem M. Abedin, MD
Intervention / Treatment: BIOLOGICAL: Neihulizumab, 3 mg/kg, DRUG: Neihulizumab, 6 mg/kg, DRUG: Neihulizumab, 9 mg/kg, DRUG: Neihulizumab